MFDS
- Status: likely_approved
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS) regulatory status in South Korea.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS has authorised it; MFDS has authorised it; MFDS has authorised it.
Marketing authorisation holder not available in our data.